Zobrazeno 1 - 10
of 56
pro vyhledávání: '"E, Ortqvist"'
Autor:
Sabina, Resic-Lindehammer, K, Larsson, E, Ortqvist, A, Carlsson, E, Cederwall, C M, Cilio, S-A, Ivarsson, B A, Jönsson, H E, Larsson, K, Lynch, J, Neiderud, A, Nilsson, S, Sjöblad, A, Lernmark, M, Aili, L E, Bååth, E, Carlsson, H, Edenwall, G, Forsander, B W, Granstro, I, Gustavsson, R, Hanås, L, Hellenberg, H, Hellgren, E, Holmberg, H, Hörnell, Sten-A, Ivarsson, C, Johansson, G, Jonsell, K, Kockum, B, Lindblad, A, Lindh, J, Ludvigsson, U, Myrdal, K, Segnestam, L, Skogsberg, L, Strömberg, U, Ståhle, B, Thalme, K, Tullus, T, Tuvemo, M, Wallensteen, O, Westphal, J, Aman
Publikováno v:
Acta Diabetologica. 45:231-235
The aim of this study was to compare the frequency of human leukocyte antigen (HLA) genotypes in 1-18-year-old patients with type 1 diabetes newly diagnosed in 1986-1987 (n = 430), 1996-2000 (n = 342) and in 2003-2005 (n = 171). We tested the hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a68569961eaba4d39479c63d6c074fd8
https://doi.org/10.1007/s00592-008-0048-5
https://doi.org/10.1007/s00592-008-0048-5
Autor:
E Ortqvist, Mona Landin-Olsson, Carolyn J. Padoa, James W. Thomas, Carina Törn, T. R. Hall, Christiane S. Hampe
Publikováno v:
Clinical and Experimental Immunology. 146:9-14
Summary Autoantibodies to insulin (IAA) are one of the first markers of the autoimmune process leading to type 1 diabetes (T1D). While other autoantibodies in T1D have been studied extensively, relatively little is known about IAA and their binding s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da644f98fa0372f95d7fe81519ea2e6c
https://doi.org/10.1111/j.1365-2249.2006.03178.x
https://doi.org/10.1111/j.1365-2249.2006.03178.x
Publikováno v:
Journal of Autoimmunity. 18:49-53
Autoantibodies to GAD65 (GAD65Ab) are prominent in type 1 diabetes. These autoantibodies may be present both years before and after the clinical diagnosis of type 1 diabetes and are widely used as a marker for the disease. Recently it has been demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::739f278d8db93c476c027dad9d4e87ab
https://doi.org/10.1006/jaut.2001.0564
https://doi.org/10.1006/jaut.2001.0564
Autor:
B, Jonsdottir, C, Andersson, A, Carlsson, A, Delli, G, Forsander, J, Ludvigsson, C, Marcus, U, Samuelsson, E, Ortqvist, A, Lernmark, S-A, Ivarsson, H Elding, Larsson, A -L, Fureman
Publikováno v:
Diabetologia; 56(8), pp 1735-1742 (2013)
AIMS/HYPOTHESIS: The aim of this work was to investigate, in children newly diagnosed with type 1 diabetes: (1) the prevalence of autoantibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TGAb); and (2) the association between TPOAb, TGAb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fb6f9f2939f1efe1e3a699513b4ff25
http://lup.lub.lu.se/record/3804571/file/4281035.pdf
http://lup.lub.lu.se/record/3804571/file/4281035.pdf
Autor:
Shilpa Oak, Kristian Lynch, ÅsaLinda Lethagen, Carl-David Agardh, Åke Lernmark, E Ortqvist, Christiane S. Hampe, Jessica Reichow, B Persson, Jerry P. Palmer, Ingrid Kockum, Corrado M. Cilio, Barbara Brooks-Worrell, Jared Radtke, Lynn M. Bekris
Publikováno v:
The Journal of clinical endocrinology and metabolism. 95(11)
The previously reported absence of 65-kDa glutamate decarboxylase antibody (GAD65Ab)-specific antiidiotypic antibodies (anti-Id) in type 1 diabetes (T1D) patients at clinical onset could be due to an inability to mount an antibody response to GAD65Ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a9fc48eb61fb9d2700e53448e93fa7
https://pubmed.ncbi.nlm.nih.gov/20685858
https://pubmed.ncbi.nlm.nih.gov/20685858
Autor:
James W. Thomas, Carolyn J. Padoa, Åke Lernmark, Jerry P. Palmer, Mona Landin-Olsson, Carina Törn, T. R. Hall, Nigel J. Crowther, E Ortqvist, Christiane S. Hampe, Lynn M. Bekris
SummaryAutoantibodies to insulin are often the first autoantibodies detected in young children with type 1 diabetes and can be present before the onset of clinical diabetes. These autoantibodies and their epitopes are, however, not well characterized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d54e9b2a5670b7caac18913479b0a89
https://europepmc.org/articles/PMC1809383/
https://europepmc.org/articles/PMC1809383/
Autor:
M.-A. Pulkkinen, Peter Bang, Christine Carlsson-Skwirut, J. Salemyr, A.-L.B. Brorsson, E. Ortqvist, Klas Ekström
Publikováno v:
Growth Hormone & IGF Research. 22:S27-S28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::290316214c51c368e397c941d3ea78d9
https://doi.org/10.1016/s1096-6374(12)60073-2
https://doi.org/10.1016/s1096-6374(12)60073-2
Autor:
J. Salemyr, Peter Bang, Christine Carlsson-Skwirut, K. Ekströ, E. Ortqvist, M.-A. Pulkkinen, A.-L.B. Brorsson
Publikováno v:
Growth Hormone & IGF Research. 22:S51-S52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::870fb8de1eb4ece717cd8924f8f7692a
https://doi.org/10.1016/s1096-6374(12)60135-x
https://doi.org/10.1016/s1096-6374(12)60135-x
Autor:
C S, Hampe, L P, Hammerle, L, Bekris, E, Ortqvist, I, Kockum, O, Rolandsson, M, Landin-Olsson, C, Törn, B, Persson, A, Lernmark
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(12)
Autoantibodies against the smaller isoform of glutamic acid decarboxylase (GAD) are markers for Type 1 diabetes. GAD65 autoantibody (GAD65Ab)-positive individuals in the general population are, however, mostly at low risk of developing Type 1 diabete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f68b55ea641474395599c37633b4ce8
https://pubmed.ncbi.nlm.nih.gov/11134126
https://pubmed.ncbi.nlm.nih.gov/11134126
Autor:
C S, Hampe, E, Ortqvist, O, Rolandsson, M, Landin-Olsson, C, Törn, A, Agren, B, Persson, D B, Schranz, A, Lernmark
Publikováno v:
The Journal of clinical endocrinology and metabolism. 84(2)
GAD65 autoantibodies (GAD65Ab) are important markers for type 1 (insulin-dependent) diabetes mellitus. Although most patients have GAD65Ab at the time of clinical diagnosis, there are also GAD65Ab-positive individuals in the population at low risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d35f4cc694e3bead3eb0d70b57a1482d
https://pubmed.ncbi.nlm.nih.gov/10022431
https://pubmed.ncbi.nlm.nih.gov/10022431